Werewolf Therapeutics (HOWL) Debt Ratio (2023 - 2025)
Werewolf Therapeutics (HOWL) posted quarterly Debt Ratio of 0.27 for Q3 2025, up 48.67% year-over-year from 0.18 in Q3 2024, and up 1.9% on a QoQ basis from 0.27 in Q2 2025.
Werewolf Therapeutics (HOWL) Debt Ratio (2023 - 2025) Analysis & Trends
Werewolf Therapeutics has reported Debt Ratio for 3 years, with the latest figure at 0.27 in Q3 2025.
- Debt Ratio for Q3 2025 came in at 0.27, up 48.67% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.27 (up 48.67% YoY), and the FY2024 annual result was 0.21, up 10.07% from the prior year.
- Debt Ratio improved to 0.27 in Q3 2025, from 0.27 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.27 in Q3 2025 and troughed at 0.16 in Q1 2024.
- A 3-year average of 0.21 and a median of 0.21 in 2024 frame the typical range for Debt Ratio.
- The widest annual swing landed in 2024, when Debt Ratio slipped 22.53%; it then surged 63.02% in 2025.
- A 3-year view of Debt Ratio shows it stood at 0.19 in 2023, then rose by 10.07% to 0.21 in 2024, then soared by 32.29% to 0.27 in 2025.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.27 in Q3 2025, 0.27 in Q2 2025, and 0.25 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.19 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.20 |